Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant
Clinical trial NCT04933968 · TERMINATED
Trial details
- NCT number
- NCT04933968
- Sponsor
- AlloVir
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2024-01-31
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.